Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study
The present study aimed to determine the possible correlation between medical treatment [oral antipsychotics (OAP), long-acting injectable antipsychotics (LAI), oral + long-acting injectable antipsychotics (OAP + LAI)] and symptom severity, and the compliance of schizophrenia patients with the medic...
Main Authors: | Asli Kazgan, Sevler Yildiz, Osman Kurt, Sevda Korkmaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of TURAZ AKADEMI
2021-09-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=63800 |
Similar Items
-
Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update
by: Balázs, T., et al.
Published: (2022) -
Problems with the Administration of Antipsychotic Drugs in Depot Formulations in the Treatment of Schizophrenia
by: Ranković Anica, et al.
Published: (2018-03-01) -
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016-04-01) -
Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up
by: Chen-Chung Liu, et al.
Published: (2015-06-01) -
Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
by: Orietta Zaniolo, et al.
Published: (2019-02-01)